Kathleen Hollis Hammonds, MD
NPI 1235336777ActiveIndividual· Internal Medicine, Pulmonary Disease· Suffolk, VA
Internal Medicine, Pulmonary Disease (MD) in Suffolk, Virginia, trained at University of Mississippi School of Medicine (class of 2007). Their prescriptions cost Medicare Part D more than their services did: $607,983 for 964 claims, against $109,934 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 13 companies reporting payments in 2025, $2,618 in all, mostly food and beverage.
Overview
| NPI | 1235336777 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jun 28, 2007 |
| Last updated in NPPES | Oct 6, 2025 |
| Certified by provider | Oct 6, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 0101247625 | VA |
| Student in an Organized Health Care Education/Training Program | 390200000X | 0116019609 | VA |
| Internal Medicine, Critical Care Medicine | 207RC0200X | 4301111818 | MI |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (IN); Practitioner - Critical Care (Intensivists) (NC); Practitioner - Pulmonary Disease (VA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 291 |
|---|---|
| Services billed | 2,079 across 36 procedure codes |
| Paid by Medicare | $109,934 |
Part D prescriptions in 2024
| Prescriptions (claims) | 964 · 1,299 30-day fills |
|---|---|
| Patients | 154 |
| Total drug cost | $607,983 |
| Generic share | 47% of claims |
Education and affiliations
| Medical school | University of Mississippi School of Medicine |
|---|---|
| Graduation year | 2007 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists) |
Medical group
- Bayview Physician Services PCChesapeake, VA · 310 clinicians
Hospital affiliations
- Bon Secours Maryview Medical CenterPortsmouth, VA
- Chesapeake General HospitalChesapeake, VA
- Sentara Norfolk General HospitalNorfolk, VA
- Sentara Obici HospitalSuffolk, VA
- Sentara Virginia Beach General HospitalVirginia Beach, VA
Industry payments (Open Payments)
- 2025$2,618 · 151 payments from 13 companies
- 2024$2,020 · 120 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $880.24 | 60 |
| Genzyme Corporation | $407.46 | 21 |
| Glaxosmithkline, LLC. | $346.17 | 19 |
| Regeneron Healthcare Solutions, Inc. | $254.80 | 11 |
| Amgen Inc. | $203.08 | 10 |
What the 2025 payments were for
- Food and Beverage$2,542 · 148 payments
- Education$76.30 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Pulmonary Disease providers in Suffolk
- 1982337242
- 1275132235
- 1134649502
- 1982660767
- 1467478727
- 1649233917
- 1982056313
All Internal Medicine, Pulmonary Disease providers in Virginia →